<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Allergy Clin Immunol Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Allergy Clin Immunol Pract</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The journal of allergy and clinical immunology. In practice</journal-title></journal-title-group><issn pub-type="ppub">2213-2198</issn><issn pub-type="epub">2213-2201</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10272084</article-id><article-id pub-id-type="pmcid-ver">PMC10272084.1</article-id><article-id pub-id-type="pmcaid">10272084</article-id><article-id pub-id-type="pmcaiid">10272084</article-id><article-id pub-id-type="manuscript-id">NIHMS1886033</article-id><article-id pub-id-type="pmid">36948493</article-id><article-id pub-id-type="doi">10.1016/j.jaip.2023.03.017</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1886033</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1886033</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of reported NSAID adverse drug reactions with opioid prescribing following total joint arthroplasty</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="L">Lily</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chang</surname><given-names initials="Y">Yuchiao</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Losina</surname><given-names initials="E">Elena</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Costenbader</surname><given-names initials="KH">Karen H.</given-names></name><degrees>MD, MPH</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="AF">Antonia F.</given-names></name><degrees>MD, MBA</degrees><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Laidlaw</surname><given-names initials="TM">Tanya M.</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston</aff><aff id="A2"><label>2</label>Department of Medicine, Harvard Medical School, Boston</aff><aff id="A3"><label>3</label>Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston</aff><aff id="A4"><label>4</label>Department of Orthopedic Surgery, Brigham and Women&#8217;s Hospital, Boston</aff><aff id="A5"><label>5</label>Department of Orthopedic Surgery, Harvard Medical School, Boston</aff><aff id="A6"><label>6</label>Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Lily Li, MD, Brigham and Women&#8217;s Hospital, Division of Allergy and Clinical Immunology, 60 Fenwood Road, 5002D, Boston, MA 02446, Telephone: 617-525-6332, <email>lilyli@bwh.harvard.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>3</month><year>2023</year></pub-date><volume>11</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">438380</issue-id><fpage>1891</fpage><lpage>1898.e3</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 12:25:14.010"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1886033.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Nonsteroidal anti-inflammatory drugs (NSAIDs) are indicated for post-operative pain management, but use may be precluded by report of adverse drug reactions (ADRs). The effect of NSAID ADR labeling on opioid prescribing following total joint arthroplasty (TJA) is unknown.</p></sec><sec id="S2"><title>Objective:</title><p id="P2">To assess the association between NSAID ADRs and post-operative opioid prescribing following TJA, a common surgical procedure.</p></sec><sec id="S3"><title>Methods:</title><p id="P3">We performed a retrospective cohort study of adults undergoing total joint (knee or hip) replacement in a single hospital network between 4/1/2016&#8211;12/31/2019. Demographic information, clinical and surgical characteristics, and prescription data were obtained from the electronic health record. We studied the association between reported NSAID ADRs and post-operative opioid prescribing in a propensity score-matched sample over one year of follow-up.</p></sec><sec id="S4"><title>Results:</title><p id="P4">NSAID ADRs were reported by 9.6% of the entire cohort (n=584/6,091). NSAID ADR was associated with 41% higher odds of receipt of opioid prescriptions at 181&#8211;365 days following hospital discharge (95% confidence interval 13%&#8722;75%) in a propensity score-matched sample. Over 98% of individuals received an opioid prescription at time of hospital discharge, with no difference in overall median opioid dose prescribed by NSAID ADR status. However, more patients with NSAID ADRs (7.6% vs 4.7%) received cumulative opioid doses &#8805;750 morphine milligram equivalents (MME) at discharge (p=0.004).</p></sec><sec id="S5"><title>Conclusion:</title><p id="P5">Reported NSAID ADR was associated with increased risk for prolonged receipt of opioids at 181&#8211;365 days post-operatively. Patients with NSAID ADRs more frequently received cumulative opioid doses &#8805;750 MME at discharge following TJA. Clarification and evaluation of reported NSAID ADRs may be particularly beneficial for surgical patients at high risk for prolonged receipt of opioids.</p></sec></abstract><kwd-group><kwd>Aspirin</kwd><kwd>non-steroidal anti-inflammatory drug (NSAID)</kwd><kwd>hypersensitivity</kwd><kwd>drug allergy</kwd><kwd>adverse drug reaction</kwd><kwd>opioid use disorder</kwd><kwd>analgesics</kwd><kwd>orthopaedic surgery</kwd><kwd>total joint arthroplasty</kwd><kwd>utilization</kwd><kwd>electronic health record</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>